Synergistic depression of NMDA receptor-mediated transmission by ketamine, ketoprofen and L-NAME combinations in neonatal rat spinal cords in vitro

British Journal of Pharmacology

Volumn 153, Issue 5, 2008, Pages 1030-1042

  Lizarraga, I ^a   Chambers, J P ^b   Johnson, C B ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b MASSEY UNIVERSITY   (New Zealand)

Author keywords

Isobolographic analysis; Ketamine; L NAME; Nitric oxide synthase; NMDA receptors; Nociceptive transmission; Non steroidal anti inflammatory drugs; Spinal cord; Synergism

Indexed keywords

KETAMINE; KETOPROFEN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N(G) NITROARGININE METHYL ESTER;

ANALGESIA; ANIMAL TISSUE; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; EXCITATORY POSTSYNAPTIC POTENTIAL; IN VITRO STUDY; MONOSYNAPTIC REFLEX; MONOTHERAPY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD;

EID: 40149094948     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707638     Document Type: Article

References (71)

1. Aimar P, Pasti L, Carmignoto G, Merighi A (1998). Nitric oxide‐producing islet cells modulate the release of sensory neuropeptides in the rat substantia gelatinosa. J Neurosci 18: 10375–10388.
2. Akagi H, Konishi S, Otsuka M, Yanagisawa M (1985). The role of substance P as a neurotransmitter in the reflexes of slow time courses in the neonatal rat spinal cord. Br J Pharmacol 84: 663–673.
3. Andreeva L, Rang HP (1993). Effect of bradikinin and prostaglandins on the release of calcitonin gene‐related peptide‐like immunoreactivity from the rat spinal cord in vitro. Br J Pharmacol 108: 185–190.
4. Ashina M, Lassen LH, Bendtsen L, Jensen R, Olesen J (1999). Effect of inhibition of nitric oxide synthase on chronic tension‐type headache: a randomised crossover trial. Lancet 353: 287–289.
5. Ates M, Hamza M, Seidel K, Kotalla CE, Ledent C, Gühring H (2003). Intrathecally applied flurbiprofen produces an endocannabinoid‐dependent antinociception in the rat formalin test. Eur J Neurosci 17: 597–604.
6. Bennett GJ (2000). Update on the neurophysiology of pain transmission and modulation: Focus on the NMDA‐receptor. J Pain Symptom Manage 19: S2–S6.
7. Benrath J, Scharbert G, Gustorff B, Adams HA, Kress HG (2005). Long‐term intrathecal S(+)‐ketamine in a patient with cancer‐related neuropathic pain. Br J Anaesth 95: 247–249.
8. Bezzi P, Carmignoto G, Pasti L, Vesce S, Rossi D, Rizzini BL et al. (1998). Prostaglandins stimulate calcium‐dependent glutamate release in astrocytes. Nature 391: 281–285.
9. Bhat A‐S, Tandan SK, Kumar D, Krishna V, Prakash VR (2007). Interactions between inhibitors of inducible nitric oxide synthase and cyclooxygenase in adjuvant‐induced arthritis in female albino rats: an isobolographic study. Eur J Pharmacol 556: 190–199.
10. Björkman R, Hallman KM, Hedner J, Hedner T, Henning M (1996). Nonsteroidal antiinflammatory drug modulation of behavioral responses to intrathecal N ‐methyl‐D‐aspartate, but not to substance P and amino‐methyl‐isoxazole‐propionic acid in the rat. J Clin Pharmacol 36: 20S–26S.
11. Brockmeyer DM, Kendig JJ (1995). Selective effects of ketamine on amino acid‐mediated pathways in neonatal rat spinal cord. Br J Anaesth 74: 79–84.
12. Bulutcu F, Dogrul A, Gü MO (2002). The involvement of nitric oxide in the analgesic effects of ketamine. Life Sci 71: 841–853.
13. Channey MA (1995). Side effects of intrathecal and epidural opioids. Can J Anaesth 42: 891–903.
14. Devoghel JC (1983). Small intrathecal doses of lysine‐acetylsalicylate relieve intractable pain in man. J Int Med Res 11: 90–91.
15. Díaz‐Reval MI, Ventura‐Martínez R, Déciga‐Campos M, Terrón JA, Cabré F, López‐Muñoz FJ (2004). Evidence for a central mechanism of action of S‐(+)‐ketoprofen. Eur J Pharmacol 483: 241–248.
16. Dickenson AH (1995). Spinal cord pharmacology of pain. Br J Anaesth 75: 193–200.
17. Dingledine R, Borges K, Bowie D, Traynelis SF (1999). The glutamate receptor ion channels. Pharmacol Rev 51: 7–61.
18. Dolan S, Nolan AM (1999). N ‐methyl D‐aspartate induced mechanical allodynia is blocked by nitric oxide synthase and cyclooxygenase‐2 inhibitors. Neuroreport 10: 449–452.
19. Dudhgaonkar SP, Kumar D, Naik A, Devi AR, Bawankule DU, Tandan SK (2004). Interaction of inducible nitric oxide synthase and cyclooxygenase‐2 inhibitors in formalin‐induced nociception in mice. Eur J Pharmacol 492: 117–122.
20. Eisenach JC, Curry R, Hood DD, Yaksh TL (2002). Phase I safety assessment of intrathecal ketorolac. Pain 99: 599–604.
21. Faber ES, Chambers JP, Brugger F, Evans RH (1997). Depression of A and C fibre‐evoked segmental reflexes by morphine and clonidine in the in vitro spinal cord of the neonatal rat. Br J Pharmacol 120: 1390–1396.
22. Fairbanks CA, Schreiber KL, Brewer KL, Yu C‐G, Stone LS, Kitto KF et al. (2000). Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc Natl Acad Sci USA 97: 10584–10589.
23. Fowler CJ, Tiger G, Stenström A (1997). Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure–activity relationship. J Pharmacol Exp Ther 283: 729–734.
24. Gaitan G, Ahuir FJ, Del Soldato P, Herrero JF (2004). Comparison of the antinociceptive activity of two new NO‐releasing derivatives of the NSAID S‐ketoprofen in rats. Br J Pharmacol 143: 533–540.
25. Gonzales JM, Loeb AL, Reichard PS, Irvine S (1999). Ketamine inhibits glutamate‐, N ‐methyl‐D‐aspartate‐, and quisqualate‐stimulated cGMP production in cultured cerebral neurons. Anesthesiology 82: 205–213.
26. Gühring H, Görig M, Ates M, Coste O, Zeilhofer HU, Pahl A et al. (2000). Suppressed injury‐induced rise in spinal prostaglandin E 2 production and reduced early thermal hyperalgesia in iNOS‐deficient mice. J Neurosci 20: 6714–6720.
27. Gühring H, Hamza M, Sergejeva M, Ates M, Kotalla CE, Ledent C et al. (2002). A role for endocannabinoids in indomethacin‐induced spinal antinociception. Eur J Pharmacol 454: 153–163.
28. Harris J, Joules C, Stanley C, Thomas P, Clarke RW (2004). Glutamate and tachykinin receptors in central sensitization of withdrawal reflexes in the decerebrated rabbit. Exp Physiol 89: 187–198.
29. Hawksworth C, Serpell M (1998). Intrathecal anesthesia with ketamine. Reg Anesth Pain Med 23: 283–288.
30. Iida H, Dohi S, Tanahashi T, Watanabe Y, Takenaka M (1997). Spinal conduction block by intrathecal ketamine in dogs. Anesth Analg 85: 106–110.
31. Ilkjær S, Nielsen PA, Bach LF, Wernberg M, Dahl JB (2000). The effect of dextromethorphan, alone or in combination with ibuprofen, on postoperative pain after minor gynaecological surgery. Acta Anaesthesiol Scand 44: 873–877.
32. Kalb RG, Lidow MS, Halsted MJ, Hockfield S (1992). N ‐methyl‐D‐aspartate receptors are transiently expressed in the developing spinal cord ventral horn. Proc Natl Acad Sci USA 89: 8502–8506.
33. Kawamata T, Omote K (1999). Activation of spinal N ‐methyl‐D‐aspartate receptors stimulates a nitric oxide/cyclic guanosine 3′,5′‐monophosphate/glutamate release cascade in nociceptive signaling. Anesthesiology 91: 1415–1424.
34. Lauretti GR, Oliveira AP, Rodrigues AM, Paccola CA (2001). The effect of transdermal nitroglycerin on spinal S(+)‐ketamine antinociception following orthopedic surgery. J Clin Anesth 13: 576–581.
35. Liaw WJ, Stephens RL, Binns BC, Chu Y, Sepkuty JP, Johns RA et al. (2005). Spinal glutamate uptake is critical for maintaining normal sensory transmission in rat spinal cord. Pain 115: 60–70.
36. Lizarraga I, Chambers JP, Johnson CB (2006). Depression of NMDA‐receptor‐mediated segmental transmission by ketamine and ketoprofen, but not L‐NAME, on the in vitro neonatal rat spinal cord preparation. Brain Res 1094: 57–64.
37. Lizarraga I, Chambers JP, Johnson CB (2007). Developmental changes in threshold, conduction velocity, and depressive action of lignocaine on dorsal root potentials from neonatal rats are associated with maturation of myelination. Can J Physiol Pharmacol 85: 251–263.
38. Lizarraga I, Chambers P, Johnson CB (2005). Synergistic depression of nociceptive responses by ketoprofen and L‐NAME in the neonatal rat hemisected spinal cord preparation. Abstracts 11th World Congress on Pain. IASP Press: Seattle. 21–26 August, 2005, Sydney, Australia, p 249 (abstract).
39. Long SK, Smith DA, Siarey RJ, Evans RH (1990). Effect of 6‐cyano‐2,3‐dihydroxy‐7‐nitro‐quinoxaline (CNQX) on dorsal root‐, NMDA‐, kainate‐ and quisqualate‐mediated depolarization of rat motoneurones in vitro. Br J Pharmacol 100: 850–854.
40. Lorenzetti BB, Ferreira SH (1996). Activation of the arginine‐nitric oxide pathway in primary sensory neurons contributes to dipyrone‐induced spinal and peripheral analgesia. Inflamm Res 45: 308–311.
41. Lozano‐Cuenca J, Castañeda‐Hernández G, Granados‐Soto V (2005). Peripheral and spinal mechanisms of antinociceptive action of lumiracoxib. Eur J Pharmacol 513: 81–91.
42. Malmberg AB, Yaksh TL (1992). Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cycooxygenase inhibition. Science 257: 1276–1279.
43. Miyawaki I, Nakamura K, Yokubol B, Kitamura R, Mori K (1997). Suppression of cyclic guanosine monophosphate formation in rat cerebellar slices by propofol, ketamine and midazolam. Can J Anaesth 44: 1301–1307.
44. Morgan CV, Babbedge RC, Gaffen Z, Wallace P, Hart SL, Moore PK (1992). Synergistic anti‐nociceptive effect of L‐ N G ‐nitro arginine methyl ester (L‐NAME) and flurbiprofen in the mouse. Br J Pharmacol 106: 493–497.
45. Morris R, Southam E, Gittins SR, de Vente J, Garthwaite J (1994). The NO–cGMP pathway in neonatal rat dorsal horn. Eur J Neurosci 6: 876–879.
46. Mueller RA, Hunt R (1998). Antagonism of ketamine‐induced anesthesia by an inhibitor of nitric oxide synthesis: a pharmacokinetic explanation. Pharmacol Biochem Behav 60: 15–22.
47. Newman AH, Jamshed HS, Izenwasser S, Heller B, Mattson M, Tortella FC (1996). Highly selective sigma1 ligands based on dextromethorphan. Med Chem Res 6: 102–117.
48. Park YH, Shin CY, Lee TS, Huh IH, Sohn UD (2000). The role of nitric oxide and prostaglandin E2 on the hyperalgesia induced by excitatory amino acids in rats. J Pharm Pharmacol 52: 431–436.
49. Porreca F, Jiang Q, Tallarida RJ (1990). Modulation of morphine antinociception by peripheral [Leu 5 ]enkephalin: a synergistic interaction. Eur J Pharmacol 179: 463–468.
50. Price DD, Mao J, Lu J, Caruso FS, Frenk H, Mayer DJ (1996). Effects of the combined oral administration of NSAIDs and dextromethorphan on behavioral symptoms indicative of arthritic pain in rats. Pain 68: 119–122.
51. Richardson JD, Aanonsen L, Hargreaves KM (1998). Antihyperalgesic effects of spinal cannabinoids. Eur J Pharmacol 345: 145–153.
52. Rivot JP, Sousa A, Montagne‐Clavel J, Besson JM (1999). Nitric oxide (NO) release by glutamate and NMDA in the dorsal horn of the spinal cord: an in vivo electrochemical approach in the rat. Brain Res 821: 101–110.
53. Sakai M, Minami T, Hara N, Nishihara I, Kitade H, Kamiyama Y et al. (1998). Stimulation of nitric oxide release from rat spinal cord by prostaglandin E 2. Br J Pharmacol 123: 890–894.
54. Sandrini G, Tassorelli C, Cecchini AP, Alfonsi E, Nappi G (2002). Effects of nimesulide on nitric oxide‐induced hyperalgesia in humans: a neurophysiological study. Eur J Pharmacol 450: 259–262.
55. Southall MD, Vasko MR (2001). Prostaglandin receptor subtypes, EP3C and EP4, mediate the prostaglandin E 2 ‐induced cAMP production and sensitization of sensory neurons. J Biol Chem 276: 16083–16091.
56. Tallarida RJ (2000). Drug Synergism and Dose–Effect Data Analysis. Chapman & Hall, CRC: Boca Raton, FL.
57. Tallarida RJ (2006). An overview of drug combination analysis with isobolograms. J Pharmacol Exp Therap 319: 1–7.
58. Tallarida RJ (2007). Interactions between drugs and occupied receptors. Pharmacol Ther 113: 197–209.
59. Tallarida RJ, Stone DJ, Raffa RB (1997). Efficient designs for studying synergistic drug combinations. Life Sci 61: PL417–PL425.
60. Thompson SWN, Babbedge R, Levers T, Dray A, Urban L (1995). No evidence for contribution of nitric oxide to spinal reflex activity in the rat spinal cord in vitro. Neurosci Lett 188: 121–124.
61. Tobin JR, Martin LD, Breslow MJ, Traystman RJ (1994). Selective anesthetic inhibition of brain nitric oxide synthase. Anesthesiology 81: 1264–1269.
62. Tonner PH, Scholz J, Lamberz L, Schlamp N, Schulte am Esch J (1997). Inhibition of nitric oxide synthase decreases anesthetic requirements of intravenous anesthetics in Xenopus laevis. Anesthesiology 87: 1479–1485.
63. Vizzard MA, Erdman SL, Forstermann U, De Groat WC (1994). Ontogeny of nitric oxide synthase in the lumbosacral spinal cord of the neonatal rat. Dev Brain Res 81: 201–217.
64. Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR (1999). Nonsteroid drug selectivities for cyclo‐oxygenase‐1 rather than cyclo‐oxygenase‐2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA 96: 7563–7568.
65. Willingale HL, Gardiner NJ, McLymont N, Giblett S, Grubb BD (1997). Prostanoids synthesized by cyclo‐oxygenase isoforms in rat spinal cord and their contribution to the development of neuronal hyperexcitability. Br J Pharmacol 122: 1593–1604.
66. Wills RJ, Martin KS (1988). Dextromethorphan/dextrorphan disposition in rat plasma and brain. Pharm Res 5: S‐193.
67. Woodley SJ, Kendig JJ (1991). Substance P and NMDA receptors mediate a slow nociceptive ventral root potential in neonatal rat spinal cord. Brain Res 559: 17–21.
68. Wu J, Kikuchi T, Wang Y, Sato K, Okumura F (2000). NOx‐ concentrations in the rat hippocampus and striatum have no direct relationship to anaesthesia induced by ketamine. Br J Anaesth 84: 183–189.
69. Yaksh TL, Dirig DM, Conway CM, Svensson C, Luo ZD, Isakson PC (2001). The acute antihyperalgesic action of nonsteroidal, anti‐inflammatory drugs and release of spinal prostaglandin E 2 is mediated by the inhibition of constitutive spinal cyclooxygenase‐2 (COX‐2) but not COX‐1. J Neurosci 21: 5847–5853.
70. Yaksh TL, Malmberg AB (1994). Interaction of spinal modulatory receptor systems. In: Fields HL, Liebeskind JC (eds). Progress in Pain Research and Management, vol. 1, IASP Press: Seattle, WA. pp 151–171.
71. Yeh C, Wu C, Lee M, Yu J, Yang C, Lu C et al. (2004). Analgesic effects of preincisional administration of dextromethorphan and tenoxicam following laparoscopic cholecystectomy. Acta Anaesthesiol Scand 48: 1049–1053.